Article
Expanding biobank pharmacogenomics through machine learning calls of structural variation.
Genetics - 9 Jul 2025
Vanderwerff Brett, Pasternak Amy L, Fritsche Lars G, Bertucci-Richter Emily, Patil Snehal, Boehnke Michael, Zhou Xiang, Zöllner Sebastian, Hertz Daniel L, Zawistowski Matthew
Abstract excerpt
Biobanks linking genetic data with clinical health records provide exciting opportunities for pharmacogenomic (PGx) research on genetic variation and drug response. Designed as central and multiuse resources, biobanks can facilitate diverse PGx research efforts, including the study of drug efficacy and adverse effects. Specialized PGx alleles and phenotypes are critical for such studies and can be conveniently...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
